CRTX fundamentals
Key facts
CRISM Therapeutics Corp. is a biotechnology company, which engages in the development of cancer treatment drugs for solid tumors. It offers ChemoSeed product which is a biodegradable drug delivery technology designed for the delivery of chemotherapy directly into cancer tissue. Its services include formulation and consultancy. It operates through the Head Office and Scientific Research segments. The Head Office segment focuses on the administrative in nature and undertaken from the United Kingdom. The Scientific Research segment relates to the work being undertaken on its key research program, ChemoSeed for glioma, and any income associated with it in the form of grants or consultancy. The company was founded in March 2016 and is headquartered in Road Town, British Virgin Islands.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company